Danaher faces revenue pressure and rising leverage despite strong market exposure, making its high valuation harder to ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

As China threatens to overtake U.S. leadership in science and technology, America has responded by sabotaging its own engines ...

The Global DNA Manufacturing Market is estimated to be valued at USD 6.44 Bn in 2025 and is expected to reach USD 19.56 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 17.2% from 2025 ...

Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.

Elena Erroba is the group CCO at 3PBIOVIAN. She specializes in the development and manufacturing of recombinant proteins and advanced therapies, including viral vectors—such as adenoviruses and ...

Should we start a second journal?” “Do we need a second journal?” “Are there too many journals already?” Those were questions ...

Amgen announced plans Sept. 2 to invest $600 million in a new, state-of-the-art center for science and innovation at its ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- Chimeric Antibody Market Growth Forecast: What To Expect By 2025? Recently, the size of the chimeric antibody market ...

Cell Non-Hodgkin Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline ...